Intercostobrachial Nerve Block vs Erector Spinae Block for Medial Arm AV Fistula Surgery
Official title: Comparison Between Ultrasound-guided Intercostobrachial Nerve Block With Supraclavicular Block Versus Ultrasound -Guided Erector Spinae Block With Supraclavicular Block for Medial Arm A-V Fistula Surgery: Observer Blinded Randomized Comparative Study
Run by Fayoum University Hospital · NCT07814703 · Data updated 2026-11-12
This study tests whether two different ultrasound-guided nerve blocks can better provide anesthesia for medial arm AV fistula surgery in patients with end-stage kidney disease.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 158 (estimated) |
| Sponsor | Fayoum University Hospital Academic / other |
| Locations | 1 site (Al Fayyum, Madīnat Al Fayyūm, Faiyum Governorate) |
| Status | Recruiting |
| Started | April 1, 2026 |
| Main results expected | April 1, 2027 |
| Study ends | June 1, 2027 |
| Registry record updated | September 11, 2026 |
| Trial ID | NCT07814703 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with ESRD undergoing medial-arm AV fistula creation, without coagulation problems or other major contraindications.
✕Probably not a fit
Patients with contraindications to regional anesthesia or resistance to nerve block techniques may not experience benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional trial compares two ultrasound-guided regional anesthesia techniques—the intercostobrachial nerve block with a supraclavicular block versus the erector spinae block with a supraclavicular block—for anesthesia in medial arm AV fistula creation. All participants receive standard monitoring, oxygen, and a supraclavicular block before the targeted regional block. The procedure uses ultrasound guidance to place injections in the coronal-oblique approach near the clavicle and brachial plexus, with lidocaine used as the local anesthetic. Eligible patients are adults with ESRD undergoing medial-arm AVF creation, excluding those with contraindications such as coagulopathy, infection at the injection site, or significant comorbidities. The lead sponsor is Fayoum University Hospital in Fayoum, Egypt.
Why it matters
Potential benefit: If successful, the preferred block could provide better anesthesia with potentially fewer side effects during medial-arm AV fistula surgery.
How similar studies have gone: Regional anesthesia innovations for vascular access surgery have shown promise in reducing anesthesia-related complications in some centers, but direct comparisons like this are limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * ESRD patient undergoing creation AVF in the medial side of the arm. Exclusion Criteria: * 1\. Patient refusal 2. Drug allergies 3. Body Mass Index of 35 kg/m² or more 4. Coagulation abnormalities 5. Severe heart, kidney, and liver diseases, 6. Pregnancy 7. Vasculitis 8. Unstable hemodynamics 9. Upper extremity neuropathy 10. Mental illness 11. Seizures 12. Contralateral chest problems 13. Infection at site of injection
Where it's running
-
Fayoum University hospital
Al Fayyum, Madīnat Al Fayyūm, Faiyum Governorate, Egypt Recruiting
Study contacts
- Study coordinator: taghreed shabaan korany, assistant lecturer
- Email: Taghreedshaban60@gmail.com
- Phone: 00201007195396
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.